HA-996 (1-hydroxy-3-aminopyrrolidone-2) selectively reduces (NMDA)-mediated brain damage
dc.contributor.author | McDonald, John W. | en_US |
dc.contributor.author | Uckele, John E. | en_US |
dc.contributor.author | Silverstein, Faye Sarah | en_US |
dc.contributor.author | Johnston, Michael V. | en_US |
dc.date.accessioned | 2006-04-07T20:41:40Z | |
dc.date.available | 2006-04-07T20:41:40Z | |
dc.date.issued | 1989-09-25 | en_US |
dc.identifier.citation | McDonald, John W., Uckele, John, Silverstein, Faye S., Johnston, Michael V. (1989/09/25)."HA-996 (1-hydroxy-3-aminopyrrolidone-2) selectively reduces (NMDA)-mediated brain damage." Neuroscience Letters 104(1-2): 167-170. <http://hdl.handle.net/2027.42/27755> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6T0G-485H7V1-186/2/164ecb1dcf21d12c28bcf3b2fd154fd1 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/27755 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2682393&dopt=citation | en_US |
dc.description.abstract | The neuroprotective effects of the strychnine-insensitive glycine receptor antagonist, HA-966, against (NMDA)- and quisqualate (QA)-mediated brain injury were determined in perinatal rats. Postnatal day (PND) 7 rats received intrastriatal injections of NMDA (25 nmol) or QA (100 nmol) and then were administered intraperitoneal (i.p.) injections of varying doses of HA-966 or vehicle 15 min later. Animals were sacrificed 5 days later and the degree of brain injury was calculated by comparison of the weights of injected and contralateral cerebral hemispheres. HA-966 selectively reduced the degree of NMDA-mediated brain injury in a dose-dependent manner. However, HA-966 did not attenuate QA-mediated brain injury. | en_US |
dc.format.extent | 269184 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | HA-996 (1-hydroxy-3-aminopyrrolidone-2) selectively reduces (NMDA)-mediated brain damage | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbsecondlevel | Psychology | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Molecular, Cellular and Developmental Biology | en_US |
dc.subject.hlbtoplevel | Social Sciences | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Neuroscience and Medical Scientist Training Program, University of Michigan Medical School, Ann Arbor MI, U.S.A. | en_US |
dc.contributor.affiliationum | Department of Pediatrics, University of Michigan Medical School, Ann Arbor MI, U.S.A.; Department of Neurology, The Johns Hopkins University School of Medicine and the Kennedy Institute, Baltimore MD, U.S.A. | en_US |
dc.contributor.affiliationum | Department of Pediatrics, University of Michigan Medical School, Ann Arbor MI, U.S.A.; Department of Neurology, The Johns Hopkins University School of Medicine and the Kennedy Institute, Baltimore MD, U.S.A. | en_US |
dc.contributor.affiliationum | Department of Neurology, University of Michigan Medical School, Ann Arbor MI, U.S.A.; Department of Pediatrics, The Johns Hopkins University School of Medicine and the Kennedy Institute, Baltimore MD, U.S.A. | en_US |
dc.identifier.pmid | 2682393 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/27755/1/0000148.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0304-3940(89)90349-2 | en_US |
dc.identifier.source | Neuroscience Letters | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.